Cargando…
ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening?
Autores principales: | Witteles, Ronald M., Reddy, Sunil A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982212/ https://www.ncbi.nlm.nih.gov/pubmed/36875904 http://dx.doi.org/10.1016/j.jaccao.2022.10.008 |
Ejemplares similares
-
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
por: Tse, Gary, et al.
Publicado: (2023) -
The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022) -
Cardio-Oncology Guidelines and Strength of the Evidence
por: Zheng, Haoyi, et al.
Publicado: (2023) -
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022) -
Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity
por: Sase, Kazuhiro, et al.
Publicado: (2022)